Aptevo Therapeutics Inc. (APVO) › Capital ExpendituresAptevo Therapeutics Inc. (APVO) — Capital ExpendituresAnnual figures by fiscal year, from SEC filings.2015: $1.53M2016: $2.51M2017: $1.40M2018: $976.0K2019: $153.0K2020: $88.0K2021: $713.0K2022: $29.0K$29.0K2015Capital Expenditures (USD)2022Fiscal YearCapital ExpendituresChange YoY2022$29.0K-95.9%2021$713.0K+710.2%2020$88.0K-42.5%2019$153.0K-84.3%2018$976.0K-30.4%2017$1.40M-44.2%2016$2.51M+64.5%2015$1.53M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowShares OutstandingDividends Per Share